Targeting FcRn to Combat Systemic Sclerosis: Promising Preclinical Advances with Efgartigimod

Introduction

Study Background and Unmet Medical Need

Study Design and Methods

Specialty calculators

Browse calculators

For clinical reference; use professional judgment.

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply